Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JCOG0909 definitive chemoradiotherapy plus salvage treatment for stage II/III esophageal carcinoma
jRCTs031180110Phase 3Completed
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of fluorouracil and cisplatin in esophageal cancer, sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Primary endpoint: 3-year overall survival. Started Jun 2010; status: completed.
02
Drugs
fluorouracilcisplatin
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on jRCTs031180110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180110.